Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for April 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Combo Antibiotics Effective in Chlamydia-Induced Arthritis
FRIDAY, April 30 (HealthDay News) -- A combination of antibiotics has been found effective in the treatment of Chlamydia-induced reactive arthritis (ReA), and may hold promise for cure of the disease, according to research published in the May issue of Arthritis & Rheumatism.
Back Pain May Lead to Higher Expenses for Other Conditions
THURSDAY, April 29 (HealthDay News) -- Incidents of low back pain are associated with increased expenditures for other health conditions, according to research published in the April 1 issue of Spine.
High BMI Plus Inactivity Increases Risk of Fibromyalgia
THURSDAY, April 29 (HealthDay News) -- Overweight and obesity are associated with an increased risk of fibromyalgia in women, particularly in those who are physically inactive or exercise less than one hour per week, according to a study in the May issue of Arthritis Care & Research.
Lumbar Fusion Associated With Improved Quality of Life
THURSDAY, April 29 (HealthDay News) -- After patients undergo lumbar fusion for degenerative lumbar stenosis with spondylolisthesis, health-related quality of life outcome measures approach those of the age-matched normal population, and are similar to improvements observed in patients after total hip and knee joint replacement surgery, according to a study in the April issue of The Spine Journal.
Risk Factors for Physician Misconduct Identified
WEDNESDAY, April 28 (HealthDay News) -- Doctors who are male, are from lower socioeconomic groups or had academic difficulties in medical school may be at increased risk of professional misconduct, according to a study published online April 27 in BMJ.
FDA Changes Medical Device Advisory Committee Process
TUESDAY, April 27 (HealthDay News) -- Because of the increasing number of medical device advisory panel meetings in recent years, the U.S. Food and Drug Administration is changing the way expert panels review and discuss information during public hearings on devices that are being reviewed for premarket approval.
Financial Ties Negatively Affect Perceptions of Research Quality
TUESDAY, April 27 (HealthDay News) -- Disclosure of financial ties to industry influences patients', physicians', and research participants' beliefs about the quality of research evidence, according to a review published in the April 26 issue of the Archives of Internal Medicine.
Most Doctors Not Knowledgeable About Herbals
MONDAY, April 26 (HealthDay News) -- Most physicians are not knowledgeable about herbal medicines and believe the general public is poorly informed as well, according to the results of a survey published in the April issue of the Drug and Therapeutics Bulletin.
Gene Variant Reduces Risk of Joint Damage in Osteoarthritis
THURSDAY, April 22 (HealthDay News) -- Having a certain variant of a gene involved in the inflammatory process may ward off joint destruction resulting from osteoarthritis (OA) in the hip and knee, though another variant is associated with an increased risk of joint destruction, according to a study published online April 8 in the Annals of the Rheumatic Diseases.
Many Women Unaware of Increased Fracture Risk
TUESDAY, April 13 (HealthDay News) -- The majority of women with risk factors for osteoporotic-associated fractures are unaware of their increased risk, according to a study published online April 1 in Osteoporosis International.
Complex Spinal Surgeries Up Among Medicare Patients
TUESDAY, April 6 (HealthDay News) -- While the overall rate of spinal stenosis surgery among Medicare beneficiaries declined slightly during 2002 to 2007, the rate of complex fusions skyrocketed, and, compared with decompression, fusion was associated with higher risks of 30-day mortality and major complications in 2007, according to a study in the April 7 issue of the Journal of the American Medical Association.
Longer Therapy No Better Than Shorter in JIA Remission
TUESDAY, April 6 (HealthDay News) -- Among patients with juvenile idiopathic arthritis (JIA), continuing methotrexate treatment for a year during remission does not prevent eventual disease relapse any better than continuing it for six months during remission, and higher myeloid-related proteins 8 and 14 heterocomplex (MRP8/14) concentrations are associated with risk of relapse after discontinuing the drug, according to a study in the April 7 issue of the Journal of the American Medical Association.
Fusion Outcome Not Correlated With Symptom Duration
FRIDAY, April 2 (HealthDay News) -- Among a group of patients who underwent posterior lumbar interbody fusion (PLIF) for chronic low back pain, outcome wasn't related to the duration of symptoms (DOS), according to research published in the March 15 issue of Spine.
Copyright © 2010 ScoutNews, LLC. All rights reserved.
|Previous: April 2010 Briefing - Pulmonology||Next: April 2010 Briefing - Surgery|
Reader comments on this article are listed below. Review our comments policy.